BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. (BTAI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTAI · as of Jun 9, 2026
Key Statistics
Explore BioXcel Therapeutics, Inc. Data
btai stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 53.3%
The BTAI analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +985.97% upside from the current price of $1.10.
Competitors & Peers
btai competitorsBTAI
ANVS
BCAB
CELU
EVAX
GBIOStock Performance
Full HistoryAbout BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. is a biopharmaceutical firm that has reached the commercial phase, distinguishing itself by leveraging artificial intelligence to advance the creation of transformative ther…
what is bioxcel therapeutics, inc. · btai stock overview · bioxcel therapeutics, inc. company profile · who is bioxcel therapeutics, inc. ceo · btai NASDAQ · bioxcel therapeutics, inc. headquarters · bioxcel therapeutics, inc. business segments
About Stock Overview & Key Data
BioXcel Therapeutics, Inc. (BTAI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 8, 2018. As of the latest trading session, BTAI stock price is $1.10, with a market capitalization of $34.1M. The stock has returned -43.62% over the past 12 months and -30.94% year-to-date.
According to 15 Wall Street analysts, the consensus rating for BioXcel Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, BioXcel Therapeutics, Inc. reported revenue of $642000.00 and net income of -$69.9M. For detailed data — including BioXcel Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioXcel Therapeutics, Inc. (BTAI) stock price is $1.10. The stock is traded on NASDAQ under the ticker symbol BTAI. The 52-week range is $1.01 – $8.08.